In Brief: Eby v. Quigley Corp. and Walgreens
This article was originally published in The Tan Sheet
Executive Summary
Eby v. Quigley Corp. and Walgreens: George Eby, who holds a patent on the use of zinc gluconate throat lozenges for reducing "the duration and severity of the common cold," alleges that the Cold-Eeze lozenges manufactured and distributed by Quigley and sold at Walgreen's retail outlets "directly infringe and violate one or more" of the patent claims. Instead of selling zinc gluconate lozenges, Eby, however, prefers to sell Fast Dry zinc acetate lozenges on the Internet -- he claims the zinc gluconate lozenges have "biting oral side effects." The complaint was filed on July 30 in the U.S. District Court for the Eastern District of Missouri, Eastern Division. According to Quigley, the suit is "without merit,...frivolous and detrimental"...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: